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ABSTRACT  
Tetrafluoropropene (R1234yf) is the most likely replacement for tetrafluoroethane (R134a), a 
widely used refrigerant, propellant and solvent, characterised by very high global warming 
potential. In this study solvation properties of R1234yf were studied experimentally and 
computationally for solubility of artemisinin, a precursor to the important bio-pharmaceutical 
API, and extraction of artemisinin from biomass. R1234yf was shown to be a poorer solvent 
than R134a for artemisinin. COSMO-RS calculations of solvation in R1234yf suggest that the 
decrease in performance is likely to be due to entropic effects. However, R1234yf was 
effectively used in solid liquid extraction of Artemisia annua. The new solvent has shown an 
increased selectivity to the target metabolite artemisinin. This should allow for design of more 
selective separation processes based on the new solvent molecule with a low global warming 
potential of 4 relative to CO2. 
 
Keywords: R1234yf, R134a, artemisinin, COSMO-RS, extraction, solubility 
 
INTRODUCTION 
Liquid-solid and liquid-liquid extraction processes are ubiquitous in industry both, as 
downstream purification methods, and as primary methods of producing molecules of interest, 
e.g., in extraction of flavour, fragrance and bioactive compounds. At the end of a process 
solvents may be recovered, but frequently are incinerated to produce energy. This represents a 
non-negligible contribution to the environmental impact of processing industries. A number 
of solvents, such as chlorinated solvents are now actively discouraged from industrial use and 
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some companies have developed internal tools to influence the choice of solvents for process 
development, e.g., GSK’s (GlaxoSmithKline) solvent selection guide.1 
 
One of the strategies to minimise environmental impact from solvents use and production is 
to encourage the use of clean solvents, such as water, supercritical carbon dioxide (scCO2), 
ionic liquids and bio-derived solvents.
2
 Among these, solvents with high boiling points 
require an additional separation step, since their distillation to recover the compounds of 
interests is not feasible, whereas scCO2, as well as other supercritical fluids (water, propane, 
etc) require only a partial de-pressurisation to recover the target compounds. This is a 
significant technological advantage, potentially leading to intensification of separation 
processes based on sc-fluids and this feature of supercritical solvents is being widely explored 
not only in separations, but also in design of new catalytic processes.
3
 
 
Another class of solvents with low boiling points are low hydrofluorocarbons (HFCs), 
amongst which tetrafluoroethane (1) has been reported as an efficient solvent for 
hydrogenations
4, 5
 and as a solvent for solid-liquid extraction from biomass.
6, 7, 8, 9 
Hydrofluorocarbons, such as tetrafluoroethane (R134a), are rather expensive to produce. 
What allowed their limited commercial applications as solvents is the large-scale use as heat 
transfer medium in refrigeration, and as a drug delivery system in inhalers.
10, 11
 The overall 
use of R134a as a solvent is negligible in comparison to the annual use, and loss to the 
environment, of R134a as a propellant and a refrigerant. However, the Montreal and Kyoto 
protocols directed signatory countries to phase out the use of compounds with high ozone 
depleting (ODP) and global warming potentials (GWP).
12, 13
 Consequently European 
Commission in May 2014 published a formal notice for registration and application for quota 
allocation to companies marketing hydrofluorocarbons (HFCs) in the EU. This was done to 
limit future sale and use of HFCs to one-fifth of 2014 use level by 2030.
14
 Similarly, in 
September 2014 the US government, with support from the manufacturing industry, 
announced commitment to further reduction in global HFC consumption by the equivalent of 
700 million tonnes of CO2 by 2025.
15
   
 
In response to this accelerated phase out of HFC’s the manufacturing industry have identified 
hydrofluoroolefins (HFOs) as a promising “next generation” replacement for HFCs in their 
most common applications as thermal fluids. Special focus is on the two main HFO isomers 
2,3,3,3-tetrafluoroprop-1-ene (R1234yf, 2) and trans-1,3,3,3-tetrafluoropro-1-ene (R1234ze). 
 3 
These substances are judged to be realistic alternatives to HFCs in industrial applications such 
as cooling media.
16
 Both isomers, R1234yf and R1234ze, have low GWPs, with atmospheric 
lifetimes of about 10.5 and 16.4 days respectively.
17
  
 
R1234yf (2) is a hydrofluoroolefin containing four fluorine atoms; see Scheme 1 with similar 
thermodynamic properties as R134a, shown for comparison in Table 1. The short atmospheric 
lifespan of hydrofluoroolefins is a consequence of the relative instability in atmospheric 
environment of the C=C double bond. As a result, the potential for instability of these fluids is 
a concern in some applications, where these are being considered as a “drop-in” replacement 
for the more stable HFCs.
18, 19
  
 
 
F
H
F
FF
H
 
 
 
F
H2C
F
FF  
 
O
H
O
CH3
H CH3
O
H
H3C
O
O
 
R134a (1)       R1234yf (2) artemisinin (3) 
 
 
CH2
OH
O
H3C
CH3
H
 
 
O
H
CH3
CH2
O
O
H3C
 
 
 
CH2
OH
O
H3C
CH3
H
 
dihydroartemisinic acid (4) arteannuin B (5) artemisinic acid (6) 
Scheme 1. Structures of molecules of interest to this study: 2,3,3,3-tetrafluoropropene 
(R1234yf), tetrafluoroethane (R134a) and metabolites of A. annua. 
 
Table 1. Physicochemical properties of R134a and R1234yf. 
Properties   R134a R1234yf References 
Boiling point Tb (K) 247.15 243.75 
20, 21
 
Critical Point Tc (K) 374 367.7 
22, 23, 24
 
 375.15 368.15 
19
 
Vapour pressure (kPa) at 293 K 572 593.4 
20
 
25
 
 4 
Molar mass (kg kmol
-1
) 102.3 114.04  
Vapour density at 298.15 K (kg m
-3
) 37.94 32.34 
22
 
Critical Pressure (MPa) 4.0593 43.382 
19
 
GWP 1430 4 
26
 
Atmospheric Life Time  14 years 11 days 
27
 
 
Consequently, stability and phase behaviour of R1234yf in different fluid systems and at a 
broad range of conditions are currently being keenly investigated, especially in the 
automotive and refrigeration industries.
28
 For applications in the refrigeration industry, Nato 
et al studying the phase equilibria of oil-refrigerant systems, found that R1234yf was more 
stable in polyolester (POE) lubricant oils than 1,1,1,2-tetrafluoroethane (R134a). However, 
R1234yf offers lower absorption rates in the oil than what was observed for R134a.
29
 
Likewise, Bobbo et al investigated solubility of R1234yf and R134a in commercial 
polyalkylene glycol (PAG) lubricants at isothermal conditions for similar applications and 
found problematic phase-separation behaviour for the R1234yf-PAG system at temperatures 
above 293.15 K.
30
 
 
To our knowledge there is no literature investigating suitability of R1234yf as a greener 
replacement fluid for hydrofluoroalkanes as an extraction solvent. Therefore, here we 
investigated experimentally and through computational modelling, the solvation properties of 
R1234yf using artemisinin and its extraction from Artemisia annua as an example of a 
currently relevant industrial bio-pharmaceutical product. 
 
EXPERIMENTAL SECTION 
Chemicals 
Artemisinin used for the solubility experiments was donated by Ipca Laboratories Ltd, (India) 
and Botanical Extracts EPZ Ltd, (Kenya). The artemisinin (>99.0 wt%) used for HPLC and 
LC-MS standard calibration was obtained from Sigma-Aldrich (UK) along with HPLC grade 
acetonitrile and LC-MS grade formic acid in water and in acetonitrile. 2,3,3,3-tetrafluoroprop-
1-ene (R1234yf) was sourced from A-gas
®
 (Bristol, UK) with the manufacturer specification 
given in Table 2. 
 
 5 
Table 2. R1234yf specification according to the manufacturer. 
Parameters Specification Units 
Purity ≥ 99.50 % wt liquid phase 
Water ≤ 10.00 ppm wt liquid phase 
Acidity ≤ 1.00 ppm wt liquid phase 
Residue ≤ 0.01 % v/v liquid phase 
Non-condensable ≤ 1.50 % v/v vapour phase at 298.15 K 
 
Solubility 
Experimental setup 
The setup included two pressurised 35 mL tube vessels (Q-tube
TM
, Sigma Aldrich) as shown 
in Figure 1. The vessels were connected by PTFE tubing (OD 3.175 mm) via an HPLC pump 
(Knauer) of a Vapourtec
TM
 R2 pumping unit (UK) and a backpressure regulator (BPR, 87 
psi). The aluminum headers of the Q-tube vessels were modified, each fitted with a medium-
pressure metering valve (Swagelok 
TM
 UK), and feed vessel was equipped with a pressure 
gauge. Samples/solvent were withdrawn from the feed vessel via an immersed sample tube 
(120 mm) with a custom built 6 mm OD, 7 mm length, filter end-cup to hold filters (Green 
Combi, Swan 
TM
). The feed vessel was thermostated to the required temperature (T1) using a 
water-recirculating bath (K20 ThemoScientific, UK). The pump head was cooled with an ice 
pack (T2). 
 
Figure 1. Schematic diagramme of the solubility measurements setup. 
 
The receiver vessel was kept cool in an icebox (T3). R1234yf (or R134a) cylinder or methanol 
containing vessel were connected to the feed vessel via a shut-off valve. 
 
Batch solubility measurements with solvent removal by pumping 
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Excess artemisinin (~ 600 mg) was weighed and placed in the feed vessel along with a 
magnetic bar. The vessel and its content were weighed before and after adding about 20 mL 
of R1234yf (or R134a) from a pressurised cylinder. The solvent level in the vessel was 
marked. The vessel and content were sonicated in a thermostated sonication bath for 30 min at 
~ 5 degrees above the target solubility temperature (283, 293, 303 and 313 K). Temperature 
during sonication was kept relatively constant by stirring into the bath small pieces of ice 
when necessary.  After sonication the vessel was transferred to the water bath, thermostated to 
the target temperature and solution was left to equilibrate over two hours under gentle stirring. 
Thereafter stirring was stopped and the system allowed to equilibrate for further 30 min. The 
metering valve on the feed vessel was open and about 10-12 mL of solution was pumped into 
the receiver vessel. The new solution level in the feed vessel was marked. Feed vessel was 
disconnected from the system and weighed. The receiving vessel was slowly de-pressurised 
allowing gentle evaporation and venting of all R1234yf (or R134a). Since saturated solution 
was pumped between the vessels, all wetted internal surfaces would be covered with the 
solute precipitate. Methanol (ca. 10 mL) was used to wash the connecting line and pump head 
from the precipitated solute into the receiving vessel. Volume of the methanol solution in the 
receiver vessel was also determined. An aliquot of the methanol solution’ filtrate was diluted 
appropriately for HPLC and LCMS analysis.  
 
The amount of artemisinin in the sample was determined by recalculating the peak area 
obtained from HPLC or MS chromatograms to the corresponding concentration using an 
external standard multi-layer calibration curve method and calculated according to Eq. 1.  
 
Amount (of sample) = Response x RF x M x D (1) 
 
where Response is the peak area in a chromatogram, RF is the response factor determined 
from a calibration curve, M is the multiplier to account for sample weight and standard purity 
factor, while D is the dilution factor used in the sample preparation. The amount of solvent 
(R1234yf/R134a) and solute (artemisinin) were thereafter expressed as moles and used to 
calculate the corresponding mole fractions.  
 
“Shake flask” method for validation of the solvent removal method 
The “shake flask” method described by Higuchi and Connors31 is the most reliable and widely 
used experimental drug solubility measurement method, even though it is relatively time 
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consuming.
32, 33
 This method was used to validate the method described above for the 
pressurised solvents. Because the “shake flask” method is not suitable for pressurised liquids 
we used methanol as an alternative solvent for the validation tests. Briefly, an excess amount 
(~150 mg) of artemisinin was added to 7 mL of anhydrous methanol (99.8 %) in a 10 mL 
glass vial containing a magnetic stirrer.  The sealed vial was placed in a thermo-stated water 
bath kept at 295 K and gently stirred at ~ 150 rpm for 25 hours to achieve a saturated solution 
in equilibrium with the solid phase. Thereafter, stirring was stopped and the content of the 
vial was allowed to phase separate over two hours.  An aliquot of the supernatant was passed 
through a syringe filter (0.2 µm, Chromacol, Thermo Scientific, UK) pre-wetted with the 
saturated solution and collected in an HPLC vial for analysis.  The corresponding flow 
method solubility measurements were conducted as for R1234yf above but with methanol as 
solvent and without the final methanol wash. An aliquot was collected in HPLC vial for 
analysis. 
 
Biomass extraction using liquid and pressurized solvents 
0.5 g of dried and grounded Artemisia annua plant leaves were extracted with ~ 20 mL of 
either ethyl acetate, hexane modified with 5% ethyl acetate or R1234yf in a comparative trial.  
The exhaustive extraction with ethyl acetate was performed based on the literature method.
6
 
All extractions with liquid solvents were carried out in 50 mL conical flasks. In the case of 
R1234yf, extraction was performed in a pressure Q-tube
TM 
(feed vessel in Figure 1). In the 
case of all solvents the biomass-solvent containing vessels were sonicated for 30 min in a 
thermo-stated bath at 295 K.  
 
In the case of conventional solvents, the extracts were filtered through a 1.0 µm (Whatman 
filter) paper to give the crude extract. 1 mL of extract was air-dried in a fume hood and 
reconstituted in 1 mL acetonitrile, which was diluted appropriately for both HPLC and LC-
MS analysis.  
 
For R1234yf the Q-tube
TM
 was filled with biomass, then solvent, and extracted as described 
above. After sonication the Q-tube was connected to the setup shown in Figure 1 as the feed 
vessel. The crude extract was filtered and pumped into the second Q-tube (receiver vessel) as 
described above. The receiver vessel was carefully depressurized to gently remove the 
solvent. The solvent-free extract left in the tube was reconstituted in an appropriate solvent 
and dilutions for analysis. 
 8 
 
HPLC analysis method 
The HPLC instrument (Shimadzu Prominence) was equipped with a degassing unit (DGU-
20A), a binary pumping module (LC-20AD), an auto-sampler (SIL-20A), a communication 
module (CBM-20A), a diode array detector module (SPD-M20A) and an oven (CTO-20AC). 
The method by Lapkin et al
34
 was used in the analysis, with modifications. Briefly, a mobile 
phase mixture of acetonitrile and water (60:40) was used in an isocratic, 15 minutes run on a 
C18 (2.7 µm 4.6 x 150 mm) Cortecs
TM
 column (Waters Ltd, USA), which was thermo-stated 
at 303 K. Chromatographic detection was at 210 nm wavelength with a 10 µL injection 
volume. 
 
Liquid chromatography method for LC-MS 
A Shimadzu Prominence HPLC system coupled to a Xevo tandem quadrupole mass 
spectrometer (Waters Corp., Milford, MA, USA) was used for the analysis of artemisinins 
based on the method by Suberu et al.
35
 Briefly, a Cortecs C18 column  (100 mm × 2.1 mm, 
2.7 µm) (Waters Corp., USA) was used for separation of the metabolites and was set to 303 
K. The mobile phase consisted of A: 0.1% formic acid in water and B: 0.1% formic acid in 
acetonitrile. Chromatographic separation was achieved using a linear gradient: 0–7.0 min, 25-
98% B; 7-9.5 min, 98% B; 9.5-10 min, 98-25% B; 10-15 min, 25% B; at a flow rate of 0.4 
mL min
-1
. 
 
Multiple reaction monitoring (MRM) method  
The tandem MS experiments were carried out in positive electrospray ionisation (ESI+) and 
acquisition was performed in MRM mode according to Suberu et al.
36
 The cone and de-
solvation gas flow rates were set at 45 and 800 L h
-1
 respectively, while the capillary voltage, 
the source and de-solvation temperatures were similar for all analytes at 40 kV, 423 and 623 
K respectively. Data were acquired by MassLynx (v. 4.1) and processed for quantification 
with QuanLynx (v. 4.1, Waters Corp., Milford, MA, USA). 
 
DSC enthalpy of fusion determination 
The enthalpy of fusion was determined for both the solute (artemisinin) and the solvent 
(R1234yf) using a Q2000 differential scanning calorimeter (TA Instruments, UK). The Q2000 
instrument was calibrated using indium (Tm = 429.75 K and Hfusion = 27.81 J g
-1
). A quantity 
of artemisinin was weighed by difference into an aluminum pan and the heat of fusion 
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determination was carried out over a temperature range of 273 to 473 K. The solvent 
(R1234yf) was also measured in the range of 113 to 273 K with a heating rate of 10 K min
-1
 
and nitrogen flow rate of 50 mL min
-1 
for both sets of experiments. A sample of R1234yf was 
cooled by dispensing an aliquot from a pressurized vessel into an empty beaker, which was 
kept in a bath of liquid nitrogen. A small liquid sample was scoped into an aluminum pan, 
which was pre-weighed and cooled with liquid nitrogen. The pan was sealed and re-weighed 
before placing into the DSC instrument for enthalpy of fusion measurement. The DSC data 
was analysed using the Universal Analysis 2000 software. 
 
Computational methods 
COSMO-RS
37
 was used for computational modeling of the solubility. COSMO-RS allows for 
the calculation of the chemical potential of liquid mixtures
38
 and can be used for predicting 
phase equilibria and liquid state thermodynamics. COSMOtherm (v. 15.0.0, COSMOlogic 
GmbH & Co. KG) was used for all COSMO-RS calculations. The starting molecular 
conformations were obtained using COSMOconf (v. 3.0, COSMOlogic GmbH & Co. KG) 
with the BP-TZVP parametrisation. In COSMO-RS, the solubility of solute j in solvent i is 
calculated according to Eq 2. 
 
log
10
x
j ,sol
= m
j ,P
- m
j ,i
-max 0,DG
fus( ) / (RT ln10) 
(2) 
where 
 
x
j ,sol
 denotes the solubility in mole fractions, m
j ,P
 and 
 
m
j ,i
 are chemical potentials of 
all compounds j in their pure form and in the mixture with i. The free energy of fusion (
 
DG
fus
 
) is needed for the calculation of absolute solubility in the case of a solid solute. In the case of 
a temperature-dependent free energy of fusion, the heat capacity of fusion  (DC
P,fus
) and 
hence 
 
DG
fus
are approximated by as given in Eq 3. 
 
DC
P,fus
» DS
fus
= DH
fus
T
m
DG
fus
(T ) = DH
fus
(1-
T
T
m
) - DC
p,fus
(T
m
-T ) + DC
P,fus
T ln
T
m
T
 
(3) 
For a qualitative comparison between solvents, activity coefficient at infinite dilution has 
been calculated and used. This quantity is obtained directly from the chemical potentials 
calculated using COSMO-RS as it is directly related to the chemical potential by Eq 4. 
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m
j
= m
j
0 +RT lna
j
 (4) 
 
where a is the activity of solute j and is given as 
 
a
j
= x
j
g
j
, 
 
g
j
 being the activity coefficient 
of solute j and xj its mole fraction. From the condition of equilibrium between two solvents, 
we know that the chemical potential and thus the activity of the solute should be equal in both 
solvents. Hence, 
 
x
S
1
g
S
1
= x
S
2
g
S
2
, where S1 and S2 denote the two solvents being compared. 
This relation makes it possible to compare the activity coefficient of a solute in two different 
solvents and draw conclusions on its mole fraction in them at the solubility limit.  
 
In COSMO-RS, each molecule is situated in a cavity surrounded by an ideal conductor, its 
surface is divided into segments and the electronic charge on it is calculated using quantum 
mechanics. Every segment is characterized by its area and the density of the so-called 
screening charge on its surface. The screening of the charge on the surface is complete at the 
presence of the ideal conductor surrounding. In COSMO-RS every molecule is then treated as 
an ensemble of interacting surface segments. The distribution of the charge density amongst 
segments is a fundamental property of each molecule in COSMO-RS and is called the -profile 
of that molecule. The calculation of the chemical potential in COSMO-RS is then done by 
statistically taking into account all possible contacts between all the segments present in a 
liquid mixture and involves various interaction energies, such as electrostatic, hydrogen 
bonding and van der Waals. 
 
RESULTS AND DISCUSSION 
Validation of the solvent flow solubility measurements  
The experimental setup for the solvent flow method was validated against a “shake flask” 
method. The use of a cellulose filter in the feed vessel Q-tube limits the range of suitable 
solvents. Acetonitrile and acetone were found to degrade the cellulose-based filter. However, 
the filter was stable in methanol, ethanol, R134a and R1234yf in our investigation.  
 
Table 3. Solubility of artemisinin (mole fraction x10
3
) in anhydrous methanol at 295 K. 
Method Replicate 1   Replicate 2 Replicate 3 
Shake flask   1.237±0.008  1.248±0.004 1.248±0.002 
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Solvent flow    1.236±0.004  1.254±0.005 1.248±0.002 
 
 
Table 3 shows the mole fraction solubility of artemisinin in anhydrous methanol at 295 K. 
This corresponds to 8.71±0.03 and 8.70±0.02 mg mL
-1
 obtained for the flow vessel and the 
‘shake flask’ methods respectively. The result also compares favourably to the 8.17 mg mL-1 
(or mole fraction 1.17±0.02 x 10
3
) value obtained by Nti-Gyabaah et al
39
 for artemisinin 
solubility in pure methanol at a similar temperature, thereby validating the solvent flow 
method of solubility determination. 
 
Experimental determination of solubility of artemisinin in R1234yf and R134a 
The experimental solubility of artemisinin in R1234yf was determined at various 
temperatures as shown in Figure 2 alongside the solubility in R134a at 293 K, shown in Table 
4. The trend observed for artemisinin solubility in R1234yf shows an increase with the 
increase in temperature over the range investigated. In terms of solubility comparison 
between the two solvents, the solubility of artemisinin in R134a was found to be about 7 
times higher that in R1234yf at 293 K. 
 
 
 
Figure 2. Experimental solubility of artemisinin in R1234yf as a function of temperature. 
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Comparatively, at low temperatures (283.15±1.00 K), the solubility of artemisinin in R1234yf 
(1.44±0.02) was superior to its solubility (mole fraction x10
3
) in methanol (0.56±0.01), 
acetonitrile (0.84±0.01), butanol (0.85±0.02), hexane (0.05±0.01) and heptane (0.05±0.01), 
reported in the literature.
39
 Even at room temperature (294.15±1.00 K), the solubility of 
artemisinin in R1234yf (1.53±0.08) is comparable to that of acetonitrile (1.57±0.04) and 
better than for methanol (1.17±0.02), hexane (0.11±0.02) and heptane (0.13±0.02). This 
would suggest that R1234yf is a better solvent for artemisinin at room and lower temperatures 
than some conventional solvents. 
 
Table 4. Solubility of artemisinin in R1234yf and in R134a at given temperatures. 
Temperature (K) 
(
o
K) 
Pressure (KPa) 
(KPa) 
Solubility  (mole fraction x 10
3
) 
R1234yf   
283.15 307.5 1.44±0.02 
293.15 450.0 1.53±0.08 
303.15 615.0 1.95±0.14 
313.15 820.0 2.38±0.26 
R134a   
                 293.15 475.0 8.55±0.13 
 
Determination of the enthalpy of fusion and the melting point  
The melting point and the enthalpy of fusion for artemisinin crystals and R1234yf used in our 
experiments are shown in  
Table 5. The two peaks in the DSC thermogram correspond to the crystalline and amorphous 
forms of artemisinin. Although a range of melting temperatures (426.15 – 432.15 K) have 
been reported in the literature for artemisinin,
39, 40, 41
 the melting temperature (Tm) obtained in 
our determination for the crystalline state (424.96 ± 0.3 K) is similar to that reported for the 
orthorhombic polymorph (424.55) by Horosanskaia et al,
40
 while the melting enthalpy (∆Hfus) 
here reported (24,545.94 ± 250.5 J mol
-1
) corresponds closely to values (24,300 ± 400 J mol
-1
) 
obtained by Nti-Gyabaah et al
39
 for artemisinin. Differences in the analytic conditions e.g., 
the heating rate employed in these DSC experiments is suggested as a possible cause for the 
variation in the reported Tm and ∆Hfus for the compound.
40
  In a previous study,
6
 the value for 
the free energy of fusion of artemisinin at 294 K was estimated to be 11.39 and 8.9 kJ mol
-1
, 
using a fitting of COSMO-RS calculations to the solubility data for ethanol and ethyl acetate, 
respectively. In this work, using the experimentally measured fusion enthalpy and 
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temperature, the free energy of fusion at 294 K calculated using Eq. 3 is 6.28 kJ mol
-1
. We 
have hence used the values obtained from our experimentally measured fusion enthalpy and 
temperature for the calculation of the free energy of fusion and subsequently the absolute 
values for the solubility of artemisinin in R1234yf at different temperatures given in Table 6. 
 
To our knowledge there are no literature values for the melting temperature and the heat of 
fusion of R1234yf. The obtained experimental values, Table 5, were used in COSMO-RS 
calculation of chemical potential of the solid solute in a liquid mixture. 
 
Table 5. Enthalpy of fusion and melting points of artemisinin and R1234yf. 
Compound Melting Temperature (K) ∆Hfus (J mol
-1
) 
Artemisinin  424.96 ± 0.3  
 
24,545.94 ± 250. 5 
R1234yf 120.18 ± 0.4 458.28 ± 46.0 
 
Computational modelling of artemisinin solubility in R1234yf and other solvents 
Figure 3A-F show the most probable configuration of artemisinin and six solvent molecules. 
The configurations were obtained using COSMOtherm, based on the contact probability of 
molecular surface segments. Each dashed line depicts a possible hydrogen bond. It can be 
seen that all hydrogen bond donors attach to the oxygen atom of the carbonyl carbon, Figure 3 
A, D and F. Further analysis showed that the second and the third oxygens correspond to the 
second and third most probable hydrogen bonds, Figure 3B. Solvents with a hydrogen 
bonding acceptor in turn attach to hydrogens on the ring, Figure 3C.  
 
 
A: artemisinin-acetonitrile 
 
B: artemisinin-water 
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C: artemisinin-acetone 
 
D: artemisinin-R134a 
 
E: artemisinin-R1234yf 
 
F: artemisinin-toluene 
Figure 3A-F. Configuration of artemisinin with various solvent molecules (ball colour - white 
= hydrogen, dark green = carbon, red = oxygen, light green = fluorine, blue = nitrogen). 
 
The absolute values of the calculated solubilities in Table 6 deviate from those obtained 
experimentally in Table 4 but are in the expected range regarding the quantitative accuracy of 
COSMO-RS in the prediction of solubility values for solid solutes.
42, 43, 44
 Qualitatively, there 
is a good agreement in the trend of solubility’s temperature dependence between the 
experimental and the computationally predicted results. 
 
Table 6. Calculated solubility of artemisinin in R1234yf. 
Temperature (K) log 10(x) Mole fraction (x 10
2
) Concentration (g L
-1
) 
283.15 -1.296 5.100 137.891 
293.15 -1.210 6.200 168.104 
303.15 -1.120 7.600 206.69 
 15 
313.15 -1.027 9.400 256.050 
 
In order to take a step toward understanding the solubility mechanism of R1234yf, individual 
contributions to the COSMO-RS chemical potential are given and compared with various 
other solvents in Figure 4. As is known from elementary thermodynamics, a larger activity 
coefficient implies a higher relative solubility. Three different energetic contributions 
depicted in Figure 4 are the misfit energy resulting from the electrostatic interaction due to 
misfit charges
45
 that remain due to deviation of the solvent from an ideal conductor, hydrogen 
bonding and van der Waals contributions. Also, the total enthalpy, i.e. the approximate sum of 
the mentioned three energetic contributions and the free energy of mixing including the 
mixing entropy, are given.  
 
 
Figure 4. Contributions to the solvation chemical potential of artemisinin in common solvents 
calculated using COSMO-RS. 
 
The solvents are listed from the highest to the lowest solubility form left to right. Comparing 
R134a with R1234yf, it can be seen from the data shown in Figure 4 and data in 
supplementary materials that the sum total of the energetic contributions are almost the same. 
The entropic contribution as found in the chemical potential, however, is the only different 
contribution between the two solvents. Considering this, it can be deduced that the reason 
why R134a is a better solvent for artemisinin than R1234yf, see Table 4, is of an entropic 
nature. One explanation can be made on the basis of the larger chain length in R1234yf than 
in R134a, the fact that both have the same number of fluorine atoms and that both can form 
dimers in the liquid phase. Formation of dimers in the liquid phase has been shown for R134a 
 16 
using Monte Carlo simulations and should in principle hold as well for R1234yf.
46
 The results 
shown in Figure 4 can be interpreted as a higher entropy loss due to disruption of the liquid 
structure caused by the introduction of solute in R1234yf. In other words, R1234yf molecules 
have, compared to R134a, a higher tendency to form an interconnected network. Much like 
the hydrophobic effect, which is a result of such a network in water, the lower solubility of 
artemisinin in both R134a and R1234yf is also a result of such a network. This effect is then 
more pronounced for R1234yf than R134a. Although a more comprehensive study of this 
effect is needed to draw clear conclusions, this could be due to a lower repulsion between the 
fluorine atoms during dimer formation of R1234yf, due to its relatively longer chain 
compared to the tightly packed R134a.  
 
From a qualitative point of view, COSMO-RS has been able to predict the difference in the 
solubility of artemisinin in R1234yf and R134a. Although a clear understanding of the 
dissolution mechanism needs a more detailed computational and experimental study of this 
system, an entropic difference is suggested by COSMO-RS as the reason behind the 
difference between the two solvents regarding artemisinin solubility. 
 
Figure 5 shows sigma profiles
45
 of the two solvents R134a and R1234yf. Sigma profiles are 
the probability distribution diagrammes of the surface screening charge as computed by 
COSMO-RS. It can be seen that R134a has a larger peak at the negative side of the screening 
charge x-axis, corresponding to the positive charge on the surface of the molecule. This leads 
to stronger hydrogen bonding donor capability, corresponding to a more negative contribution 
of the hydrogen bonding, seen in Figure 5. The more favourable van der Waals interaction 
can be associated with the larger size of the nonpolar surface of R1234yf compared to that of 
R134a, with COSMO-RS surface areas 118 and 105 Å
2
. 
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Figure 5. Sigma profiles of R134a and R1234yf. 
 
 
Extraction of A. annua with R1234yf and comparison with conventional solvents  
A similar setup for the solubility determination was used to test extraction of A. annua 
biomass with R1234yf. This was to assess suitability of the solvent for extraction of high 
value compounds from the bio-feedstock. The extraction efficiency for the solvent was based 
on exhaustive extraction of the biomass with ethyl acetate.
34
 Sequential extraction over three 
extraction cycles gives an estimate for the amount of a target metabolite in the plant against 
which the extraction power of solvents for each metabolite was benchmarked to determine the 
efficiency of extraction shown in Figure 6.  
 
 
 18 
 
Figure 6. Efficiency of metabolite extraction with R1234yf (HFO) using method 1, hexane 
modified with 5% of ethyl acetate (Hex), and pure ethyl acetate (EA).  
 
Comparatively, R1234yf demonstrated the best extraction efficiency for artemisinin 
(99.81±13.48 %) of all the solvents evaluated with almost a complete extraction of the 
metabolite. R1234yf performed better for the extraction of artemisinin than a single extraction 
cycle with ethyl acetate (91.06±2.35 %) and the modified hexane (95.61±3.74 %, Table 7).  
 
 
Table 7. Comparative analysis of extraction of A. annua biomass with R1234yf and 
conventional solvents. 
Metabolites R1234yf 
 
Hexane with 
5% EA 
Ethyl acetate 
(EA) 
Exhaustive 
extraction with 
EA 
Artemisinin (mg g
-1
) 12.28±1.86 11.76±0.44 11.2±0.26  12.30±3.20 
Dihydroartemisinin  
(mg g
-1
) 
1.40±0.51 1.45±0.13 2.46±0.03  2.60±0.05 
Artemisinic acid (mg g
-1
) 0.25±0.06 0.30±0.03 0.32±0.07  0.35±0.08 
Arteannuin B (µg g
-1
) 60.52±4.82 76.13±4.53 66.92±6.00  85.79±7.17 
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R1234yf performed poorer relative to the other solvents evaluated for the extraction of 
dihydroartemisinic acid, arteannuin B and artemisinic acid. Ethyl acetate extracted above 80% 
of all artemisinin-related metabolites evaluated. For the extraction of DHAA, R1234yf and 
modified hexane performed moderately at less than 60 % efficiency. Consequently, the 
obtained results show that if the extraction of artemisinin is the main goal, R1234yf is the 
solvent of choice among those investigated. 
 
Artemisinin in crude extract 
The R1234yf dried primary extract of A. annua biomass was analysed by HPLC and results 
are shown in Figure 7 with the artemisinin peak identified. Artemisinin content in the primary 
extract was found to be 29.57±0.78 wt%. This is the upper limit of the range reported in 
literature for R134a (20-30 wt%) and superior to the values for crude ethanol (<10 %), hexane 
and toluene extracts (10-15% each).
9
  
 
 
Figure 7. HPLC chromatogram of A. annua primary extract using R1234yf as extraction 
solvent. 
 
Although the current investigation did not include purification of the primary extract, in an 
earlier work with conventional solvents we employed celite and activated carbon in the first 
step of purification of artemisinin extracts.
34, 47
 A packed column containing these adsorbents 
and inserted in the flow extraction after the biomass bed is therefore an attractive and simple 
option of primary extract purification.  
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CONCLUSIONS 
The replacement for thermal fluid R134a, being phased out due to its exceptionally high 
global warming potential, tetrafluoropropene (R1234yf, 2) was studied for the first time as a 
potential new process solvent. It was studied in solubility of a drug API precursor, artemisinin 
(3), and in solid-liquid extraction of the same molecule. The new solvent was found to be 
comparable or better to many conventional solvents in solubility of artemisinin, especially at 
low temperatures. It was also found to be more selective towards artemisinin in solid-liquid 
extraction from biomass. The concentration of artemisinin in the R1234yf primary extract was 
superior to those reported for ethanol, hexane and toluene and similar to R123a extraction.
9
 
This is a significant differentiation of the new solvent compared to most solvents previously 
investigated for this process.  
 
Computational study of the new solvent’s solvation mechanism suggested that its poorer 
solvation compared to R134a is due to entropic factors. COSMO-RS predictions are shown to 
meet the expected quantitative agreement with the experimentally measured solubility values 
and qualitatively match the solubility-temperature trend observed. 
 
Given its excellent performance in solid-liquid extraction, its low GWP, and the earlier 
reported low process costs and process emissions from an extraction process based on 
R134a,
6
 which has very similar physical properties to R1234yf, the new solvent should 
outperform scCO2 in a number of industrially relevant extraction processes and in chemical 
manufacturing, and thus has a potential to become a green process solvent 
48, 49
 in processes 
that allow full solvent recovery and recycle. 
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1. Energy graphs 
Table S1 shows the data used in the plot of the energy graphs, Figure 4. 
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